- Matteson EL, Dejaco C. In the clinic: polymyalgia rheumatica. Ann Intern Med. 2017;166(9):ITC65. doi:https://doi.org/10.7326/AITC201705020.
- Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484–492. doi:https://doi.org/10.1136/annrheumdis-2011-200329.
- Dejaco C, Singh YP, Perel P, et al. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheumatol. 2015;67(10):2569–2580. doi:https://doi.org/10.1002/art.39333.
- Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD. Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis. 2014;73(10):1769–1773. doi:https://doi.org/10.1136/annrheumdis-2013-203465.
- Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford). 2010;49(6):1158–1163. doi:https://doi.org/10.1093/rheumatology/keq040.
- Enomoto LM, Levine EA, Shen P, Votanopoulos KI. Role of surgery for metastatic melanoma. Surg Clin North Am. 2020;100(1):127–139. doi:https://doi.org/10.1016/j.suc.2019.09.011.
- Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current perspectives in cancer immunotherapy. Cancers (Basel). 2019;11(10):1472. doi:https://doi.org/10.3390/cancers11101472.
- Goldstein BL, Gedmintas L, Todd DJ. Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of CTLA-4. Arthritis Rheumatol. 2014;66(3):768–769. doi:https://doi.org/10.1002/art.38282.
- Steven NM, Fisher BA. Management of rheumatic complications of immune checkpoint inhibitor therapy—an oncological perspective. Rheumatology (Oxford). 2019;58(Suppl 7):vii29–vii39. doi:https://doi.org/10.1093/rheumatology/kez536.
- Richter MD, Crowson C, Kottschade LA, Finnes HD, Markovic SN, Thanarajasingam U. Rheumatic syndromes associated with immune checkpoint inhibitors: a single-center cohort of sixty-one patients. Arthritis Rheumatol. 2019;71(3):468–475. doi:https://doi.org/10.1002/art.40745.
A paraneoplastic syndrome exacerbated by checkpoint inhibition therapy
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.